Journal ArticleOPEN ACCESS

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV

  • Paton N
  • Musaazi J
  • Kityo C
  • et al.
New England Journal of Medicine (2021) 385(4) 330-341
DOI: 10.1056/nejmoa2101609
157Citations
Citations of this article
208Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background The World Health Organization recommends dolutegravir with two nucleoside reverse-transcriptase inhibitors (NRTIs) for second-line treatment of human immunodeficiency virus type...

Cite

CITATION STYLE

APA

Paton, N. I., Musaazi, J., Kityo, C., Walimbwa, S., Hoppe, A., Balyegisawa, A., … Kambugu, A. (2021). Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. New England Journal of Medicine, 385(4), 330–341. https://doi.org/10.1056/nejmoa2101609

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free